Get started
Amplia Therapeutics Ltd.Amplia Therapeutics Ltd.Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪55.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0133 USD
Net income (FY)
‪−4.10 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪479.03 M‬
Beta (1Y)
−3.18

About Amplia Therapeutics Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher J. Burns
Website
ampliatx.com
Headquarters
Melbourne
Founded
2013
IPO date
Dec 23, 2013
Identifiers
2
ISIN AU0000023822
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. Its immuno-modulator microparticles technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as multiple sclerosis. The company was founded by Christopher J. Burns on May 31, 2000 and is headquartered in Melbourne, Australia.

Check out other big names from the same industry as INNMF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of INNMF is 0.1200 USD — it has decreased by −7.69% in the past 24 hours. Watch Amplia Therapeutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Amplia Therapeutics Ltd. stocks are traded under the ticker INNMF.
INNMF stock has risen by 22.45% compared to the previous week, the last month showed zero change in price, over the last year Amplia Therapeutics Ltd. has showed a 221.72% increase.
We've gathered analysts' opinions on Amplia Therapeutics Ltd. future price: according to them, INNMF price has a max estimate of 0.29 USD and a min estimate of 0.29 USD. Watch INNMF chart and read a more detailed Amplia Therapeutics Ltd. stock forecast: see what analysts think of Amplia Therapeutics Ltd. and suggest that you do with its stocks.
INNMF reached its all-time high on Jan 26, 2017 with the price of 1.6000 USD, and its all-time low was 0.0120 USD and was reached on Nov 8, 2017. View more price dynamics on INNMF chart.
See other stocks reaching their highest and lowest prices.
INNMF stock is 8.33% volatile and has beta coefficient of −3.18. Track Amplia Therapeutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Amplia Therapeutics Ltd. there?
Today Amplia Therapeutics Ltd. has the market capitalization of ‪55.59 M‬, it has decreased by −3.35% over the last week.
Yes, you can track Amplia Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
Amplia Therapeutics Ltd. is going to release the next earnings report on Jun 1, 2026. Keep track of upcoming events with our Earnings Calendar.
Amplia Therapeutics Ltd. revenue for the last half-year amounts to ‪1.87 M‬ USD, matching the estimated figure, and no changes in revenue are expected for the next half-year.
INNMF net income for the last half-year is ‪−2.76 M‬ USD, while the previous report showed ‪−2.35 M‬ USD of net income which accounts for 0.00% change. Track more Amplia Therapeutics Ltd. financial stats to get the full picture.
No, INNMF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INNMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amplia Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amplia Therapeutics Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amplia Therapeutics Ltd. stock shows the buy signal. See more of Amplia Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.